Who to call at Evoke, and when
Fundz watches for the moments Evoke starts buying, and tells you who to reach.
- An alert the day Evoke raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Evoke, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Evoke. With Fundz connected, it knows.
Evoke
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
AI Executive Summary
AI-powered analysis of 8-K filing content
Evoke Pharma signed a Merger Agreement with QOL Medical, LLC on November 3, 2025, under which QOL-EOS Merger Sub will commence a tender offer for the company. The company also amended and restated employment agreements for three named executive officers and arranged transition services with the parent after the merger closes.
Key Takeaways
Evoke entered into a Merger Agreement with QOL Medical, LLC and its wholly owned subsidiary QOL-EOS Merger Sub, Inc., structured as a tender offer followed by a merger.
Named executive officers Matthew J. D'Onofrio, Mark Kowieski, and Marilyn R. Carlson had their employment agreements amended and restated in connection with the signing.
2 more takeaways
Related Filings (1)
1 more filing from Evoke in the last 90 days
Filing Overview
What This Means
Evoke filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.